These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 24064019)
1. Lectin-like oxidised LDL receptor-1 as a marker of endothelial dysfunction in Behçet's disease. Ozyazgan S; Uzun H; Onal B; Tuzcu A; Ugurlu S; Andican G Clin Exp Rheumatol; 2013; 31(3 Suppl 77):71-6. PubMed ID: 24064019 [TBL] [Abstract][Full Text] [Related]
2. Soluble Lectin-Like Oxidized LDL Receptor 1 as a Possible Mediator of Endothelial Dysfunction in Patients With Metabolic Syndrome. Civelek S; Kutnu M; Uzun H; Erdenen F; Altunoglu E; Andican G; Seven A; Sahin AO; Burcak G J Clin Lab Anal; 2015 May; 29(3):184-90. PubMed ID: 24798146 [TBL] [Abstract][Full Text] [Related]
3. Endothelial damage in white coat hypertension: role of lectin-like oxidized low-density lipoprotein-1. Yavuzer S; Yavuzer H; Cengiz M; Erman H; Altıparmak MR; Korkmazer B; Balci H; Simsek G; Yaldıran AL; Karter Y; Uzun H J Hum Hypertens; 2015 Feb; 29(2):92-8. PubMed ID: 25007999 [TBL] [Abstract][Full Text] [Related]
4. Serum homocysteine level is increased and correlated with endothelin-1 and nitric oxide in Behçet's disease. Er H; Evereklioglu C; Cumurcu T; Türköz Y; Ozerol E; Sahin K; Doganay S Br J Ophthalmol; 2002 Jun; 86(6):653-7. PubMed ID: 12034688 [TBL] [Abstract][Full Text] [Related]
5. Asymmetric dimethylarginine and nitric oxide levels as signs of endothelial dysfunction in Behcet's disease. Sahin M; Arslan C; Naziroglu M; Tunc SE; Demirci M; Sutcu R; Yilmaz N Ann Clin Lab Sci; 2006; 36(4):449-54. PubMed ID: 17127734 [TBL] [Abstract][Full Text] [Related]
6. Oxidised Low-Density Lipoprotein and Its Receptor-Mediated Endothelial Dysfunction Are Associated with Coronary Artery Lesions in Kawasaki Disease. He YE; Qiu HX; Wu RZ; Rong X; Xu HT; Xiang RL; Chu MP J Cardiovasc Transl Res; 2020 Apr; 13(2):204-214. PubMed ID: 31428922 [TBL] [Abstract][Full Text] [Related]
7. Plasma thiopurine S-methyltransferase levels and azathioprine-related adverse events in patients with Behçet's disease. Emmungil H; Durusoy R; Kalfa M; Yargucu Zihni F; Özmen M; Keser G; Gücenmez S; Yilmaz Z; Aksu K Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S40-5. PubMed ID: 25936353 [TBL] [Abstract][Full Text] [Related]
8. Hematological Indices May Be Useful in the Diagnosis of Systemic Lupus Erythematosus and in Determining Disease Activity in Behçet's Disease. Yolbas S; Yildirim A; Gozel N; Uz B; Koca SS Med Princ Pract; 2016; 25(6):510-516. PubMed ID: 27348861 [TBL] [Abstract][Full Text] [Related]
9. Nitric oxide, lipid peroxidation and antioxidant defence system in patients with active or inactive Behçet's disease. Buldanlioglu S; Turkmen S; Ayabakan HB; Yenice N; Vardar M; Dogan S; Mercan E Br J Dermatol; 2005 Sep; 153(3):526-30. PubMed ID: 16120137 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of lectin-like oxidized low-density lipoprotein-1 receptor protects against plasma-mediated vascular dysfunction associated with pre-eclampsia. English FA; McCarthy FP; McSweeney CL; Quon AL; Morton JS; Sawamura T; Davidge ST; Kenny LC Am J Hypertens; 2013 Feb; 26(2):279-86. PubMed ID: 23382414 [TBL] [Abstract][Full Text] [Related]
12. Synovial nitric oxide concentrations are increased and correlated with serum levels in patients with active Behçet's disease: a pilot study. Duygulu F; Evereklioglu C; Calis M; Borlu M; Cekmen M; Ascioglu O Clin Rheumatol; 2005 Aug; 24(4):324-30. PubMed ID: 15902528 [TBL] [Abstract][Full Text] [Related]
13. Induction of the oxLDL receptor LOX-1 by endothelin-1 in human endothelial cells. Morawietz H; Duerrschmidt N; Niemann B; Galle J; Sawamura T; Holtz J Biochem Biophys Res Commun; 2001 Jun; 284(4):961-5. PubMed ID: 11409887 [TBL] [Abstract][Full Text] [Related]
14. Assessment of homocysteine, neopterin and nitric oxide levels in Behçet's disease. Ozkan Y; Yardim-Akaydin S; Sepici A; Engin B; Sepici V; Simşek B Clin Chem Lab Med; 2007; 45(1):73-7. PubMed ID: 17243919 [TBL] [Abstract][Full Text] [Related]
17. [LOX-1 receptor as a novel target in endothelial dysfunction and atherosclerosis]. Morawietz H Dtsch Med Wochenschr; 2010 Feb; 135(7):308-12. PubMed ID: 20146162 [TBL] [Abstract][Full Text] [Related]
18. Urinary nitric oxide levels are increased and correlated with plasma concentrations in patients with Behçet's disease: is it a new urinary activity marker? Evereklioglu C; Ozbek E; Cekmen M; Mehmet N; Duygulu F; Ozkiris A; Calip M; Er H; Turkoz Y Nephrology (Carlton); 2003 Oct; 8(5):231-8. PubMed ID: 15012709 [TBL] [Abstract][Full Text] [Related]
19. Serum galectin-3 and galectin-3 binding protein levels in Behçet's disease and their association with disease activity. Lee YJ; Kang SW; Song JK; Park JJ; Bae YD; Lee EY; Lee EB; Song YW Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S41-5. PubMed ID: 17949550 [TBL] [Abstract][Full Text] [Related]